newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 expanded to South America Topline data anticipated in the fourth quarter of 2021 WESTMINSTER, Colo., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ:AB